FGFR2, FGFR3, FGFR1, TWIST1, and
EFNB1 genes play a role in the syndromic craniosynostosis presenting with craniofacial abnormalities, including hypertelorism, proptosis, and midfacial hypoplasia.
In the renal cortex they confirmed differences in expression of apoptosis-inducing factor, mitochondrion-associated, 1 (AIFM1), alpha-1-microglobulin/bikunin precursor (AMBP), apolipoprotein E (APOE), cluster of differentiation 36 (CD36), ephrin-B1 (
EFNB1), NADH dehydrogenase (ubiquinone) complex I, assembly factor 1 (NDUFAF1), peroxiredoxin 5 (PRDX5), REN, renin binding protein (RENBP), solute carrier family 13 (sodium/sulfate symporters), member 1 (SLC13A1), syntaxin 4 (STX4), and troponin T type 2 (cardiac) (TNNT2) mRNAs, and the miRNAs hsa-miR-21, hsa-miR-126, hsa-miR-181a, hsa-miR-196a, hsamiR-451, hsa-miR-638, and hsa-miR-663.
Genetic studies have helped in elucidating the molecular bases of this complex and heterogeneous group of developmental disorders, thanks to the identification in a number of syndromes (e.g., Apert, Crouzon, Pfeiffer, and Saethre-Chotzen craniosynostosis) of mutations in fibro-blast growth factor receptor (FGFR) [7] genes and the TWIST1, MSX2,
EFNB1, and ALPL genes (1, 2).